Thomas WD - Search Results

1

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types.

Zhang XD, Nguyen T, Thomas WD, Sanders JE, Hersey P. Zhang XD, et al. Among authors: thomas wd. FEBS Lett. 2000 Oct 6;482(3):193-9. doi: 10.1016/s0014-5793(00)02042-1. FEBS Lett. 2000. PMID: 11024459

2

Immunologically-mediated tumour cell apoptosis: the role of TRAIL in T cell and cytokine-mediated responses to melanoma.

Nguyen T, Thomas W, Zhang XD, Gray C, Hersey P. Nguyen T, et al. Forum (Genova). 2000 Jul-Sep;10(3):243-52. Forum (Genova). 2000. PMID: 11007932 Review.

3

The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells.

Franco AV, Zhang XD, Van Berkel E, Sanders JE, Zhang XY, Thomas WD, Nguyen T, Hersey P. Franco AV, et al. Among authors: thomas wd. J Immunol. 2001 May 1;166(9):5337-45. doi: 10.4049/jimmunol.166.9.5337. J Immunol. 2001. PMID: 11313369

4

TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria.

Thomas WD, Zhang XD, Franco AV, Nguyen T, Hersey P. Thomas WD, et al. J Immunol. 2000 Nov 15;165(10):5612-20. doi: 10.4049/jimmunol.165.10.5612. J Immunol. 2000. PMID: 11067917

5

TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells.

Thomas WD, Hersey P. Thomas WD, et al. J Immunol. 1998 Sep 1;161(5):2195-200. J Immunol. 1998. PMID: 9725211

6

CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95).

Thomas WD, Hersey P. Thomas WD, et al. Int J Cancer. 1998 Jan 30;75(3):384-90. doi: 10.1002/(sici)1097-0215(19980130)75:3<384::aid-ijc10>3.0.co;2-9. Int J Cancer. 1998. PMID: 9455798

7

Expression of the co-stimulatory molecule B7 on melanoma cells.

Hersey P, Si Z, Smith MJ, Thomas WD. Hersey P, et al. Among authors: thomas wd. Int J Cancer. 1994 Aug 15;58(4):527-32. doi: 10.1002/ijc.2910580413. Int J Cancer. 1994. PMID: 7520026

8

Expression of the co-stimulatory molecule CD40 on melanoma cells.

Thomas WD, Smith MJ, Si Z, Hersey P. Thomas WD, et al. Int J Cancer. 1996 Dec 11;68(6):795-801. doi: 10.1002/(SICI)1097-0215(19961211)68:6<795::AID-IJC18>3.0.CO;2-#. Int J Cancer. 1996. PMID: 8980186

9

The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation.

Raif A, Marshall GM, Bell JL, Koach J, Tan O, D'andreti C, Thomas W, Sekyere E, Norris M, Haber M, Kavallaris M, Cheung BB. Raif A, et al. Cancer Lett. 2009 May 8;277(1):82-90. doi: 10.1016/j.canlet.2008.11.030. Epub 2009 Jan 14. Cancer Lett. 2009. PMID: 19147277

10

Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification.

Hansford LM, Thomas WD, Keating JM, Burkhart CA, Peaston AE, Norris MD, Haber M, Armati PJ, Weiss WA, Marshall GM. Hansford LM, et al. Among authors: thomas wd. Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12664-9. doi: 10.1073/pnas.0401083101. Epub 2004 Aug 16. Proc Natl Acad Sci U S A. 2004. PMID: 15314226 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results